Definition: To Detect The Presence Of Genetic Markers Of Antimicrobial Resistance By Testing Isolated Bacterial Colonies Using Nucleic Acid Amplification Technology.
Device Type ID | 3571 |
Device Name | System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-susceptible Gram Negative Organism, Colony |
Physical State | Single-use, Disposable Assay Cartridge And Instrument System |
Technical Method | Qualitative Nucleic Acid Amplification Test |
Target Area | Not Applicable |
Regulation Description | Antimicrobial Susceptibility Test Powder. |
Regulation Medical Specialty | Microbiology |
Review Panel | Microbiology |
Premarket Review | Office Of In Vitro Diagnostics And Radiological Health (OIR) |
Submission Type | 510(k) |
CFR Regulation Number | 866.1640 [🔎] |
FDA Device Classification | Class 2 Medical Device |
Product Code | PMY |
GMP Exempt | No |
Summary MR | Ineligible |
Implanted Device | No |
Life Support Device | No |
Third Party Review | Not Third Party Eligible |
Device Type ID | 3571 |
Device | System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-susceptible Gram Negative Organism, Colony |
Product Code | PMY |
FDA Device Classification | Class 2 Medical Device |
Regulation Description | Antimicrobial Susceptibility Test Powder. |
CFR Regulation Number | 866.1640 [🔎] |
Premarket Reviews | ||
---|---|---|
Manufacturer | Decision | |
CEPHEID | ||
SUBSTANTIALLY EQUIVALENT | 1 |